Sepsis induces Telomere Shortening: a Potential Mechanism Responsible for Delayed Pathophysiological Events in Sepsis Survivors?

Sepsis survivors suffer from additional morbidities, including higher risk of readmissions, nervous system disturbances and cognitive dysfunction, and increased mortality, even several years after the initial episode of sepsis. In many ways, the phenotype of sepsis survivors resembles the phenotype associated with accelerated aging. Since telomere shortening is a hallmark of aging, we investigated whether sepsis also leads to telomere shortening. Male balb/c mice were divided into two groups: the control group received 100 µl of normal saline intraperitoneally (i.p.) and the sepsis group received 15 mg/kg of bacterial lipopolysaccharide i.p. After 48 h, animals were euthanized to collect blood, spleen and kidney. The human component of our study utilized blood samples obtained from patients in the trauma department and samples collected 7 d later in those patients who developed sepsis. Telomere length was measured by quantitative polymerase chain reaction. Since oxidative stress is a known inducer of telomere shortening, thiobarbituric acid-reactive substances and superoxide dismutase activity were analyzed to evaluate oxidative stress burden. Induction of endotoxemia in mice resulted in significant telomere shortening in spleen and kidney. Blood cells from patients who progressed to sepsis also exhibited a statistically significant reduction of telomere length. Endotoxemia in mice also induced an early-onset increase in oxidative stress markers but was not associated with a downregulation of telomerase protein expression. We conclude that endotoxemia and sepsis induce telomere shortening in various tissues and hypothesize that this may contribute to the pathogenesis of the delayed pathophysiological events in sepsis survivors.

[1]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[2]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[3]  D. Raj,et al.  Enhanced microglial pro‐inflammatory response to lipopolysaccharide correlates with brain infiltration and blood–brain barrier dysregulation in a mouse model of telomere shortening , 2015, Aging cell.

[4]  D. Angus,et al.  Interplay between sepsis and chronic health. , 2014, Trends in molecular medicine.

[5]  S. Humphries,et al.  Association Between Short Leukocyte Telomere Length, Endotoxemia, and Severe Periodontitis in People With Diabetes: A Cross-Sectional Survey , 2014, Diabetes Care.

[6]  C. O. Kim,et al.  Analysis of cellular senescence induced by lipopolysaccharide in pulmonary alveolar epithelial cells. , 2012, Archives of gerontology and geriatrics.

[7]  H. Galley Oxidative stress and mitochondrial dysfunction in sepsis. , 2011, British journal of anaesthesia.

[8]  M. J. Hall,et al.  Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. , 2011, NCHS data brief.

[9]  P. Pronovost,et al.  Long-term mortality and quality of life in sepsis: A systematic review* , 2010, Critical care medicine.

[10]  N. Weng Telomere and adaptive immunity , 2008, Mechanisms of Ageing and Development.

[11]  H. Moonen,et al.  Telomere length assessment: biomarker of chronic oxidative stress? , 2008, Free radical biology & medicine.

[12]  V. Mohan,et al.  Telomere shortening & metabolic/vascular diseases. , 2007, The Indian journal of medical research.

[13]  P. Lipsky,et al.  Abnormal differentiation of memory T cells in systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[14]  M. Blasco,et al.  Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  M. Langer,et al.  The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock , 1995, Intensive Care Medicine.

[16]  D. ToniDarvilleM.,et al.  The systemic inflammatory response syndrome (SIRS): Immunology and potential immunotherapy , 2005, Infection.

[17]  U. Klingmüller,et al.  Effects of Telomerase Modulation in Human Hematopoietic Progenitor Cells , 2004, Stem cells.

[18]  S. Kunkel,et al.  The chronic consequences of severe sepsis , 2004, Journal of leukocyte biology.

[19]  T. Ramasarma,et al.  Methods for estimating lipid peroxidation: an analysis of merits and demerits. , 2003, Indian journal of biochemistry & biophysics.

[20]  S. Cuzzocrea,et al.  Oxidative stress in septic shock and disseminated intravascular coagulation. , 2002, Free radical biology & medicine.

[21]  J. Shay,et al.  Human Telomerase and Its Regulation , 2002, Microbiology and Molecular Biology Reviews.

[22]  R. Cawthon Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[23]  W. Dröge Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[24]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[25]  T. Kaisho,et al.  Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. , 2001, Trends in immunology.

[26]  A. D. de Gaudio,et al.  The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. , 2000, American journal of respiratory and critical care medicine.

[27]  S. Gerondakis,et al.  Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. , 1998, The Journal of clinical investigation.

[28]  François Gouin,et al.  Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .

[29]  F Doyon,et al.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.

[30]  E. Deitch,et al.  Multiple organ failure. Pathophysiology and potential future therapy. , 1992, Annals of surgery.

[31]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[32]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[33]  R. L. Fulton,et al.  Multiple system organ failure. The role of uncontrolled infection. , 1980, Archives of surgery.

[34]  S. Marklund,et al.  Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. , 1974, European journal of biochemistry.